ReP USP - Resultado da busca

Artigo de periodico
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study (2023)
Dey, Mrinalini ; Naveen, R ; Nikiphorou, Elena ; Sen, Parikshit ; Saha, Sreoshy ; Lilleker, James B ; Agarwal, Vishwesh ; Kardes, Sinan ; Day, Jessica ; Milchert, Marcin ; Shinjo, Samuel Katsuyuki
Fonte: Rheumatology. Unidade: FM
Assuntos: COVID-19, DOENÇAS AUTOIMUNES, VACINAÇÃO, EVENTO ADVERSO A MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DEY, Mrinalini et al. Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study. Rheumatology, v. 62, n. 5, p. E147-E152, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53815. Acesso em: 03 nov. 2025.
APA
Dey, M., Naveen, R., Nikiphorou, E., Sen, P., Saha, S., Lilleker, J. B., et al. (2023). Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study. Rheumatology, 62( 5), E147-E152. doi:10.1093/rheumatology/keac603
NLM
Dey M, Naveen R, Nikiphorou E, Sen P, Saha S, Lilleker JB, Agarwal V, Kardes S, Day J, Milchert M, Shinjo SK. Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study [Internet]. Rheumatology. 2023 ; 62( 5): E147-E152.[citado 2025 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53815
Vancouver
Dey M, Naveen R, Nikiphorou E, Sen P, Saha S, Lilleker JB, Agarwal V, Kardes S, Day J, Milchert M, Shinjo SK. Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study [Internet]. Rheumatology. 2023 ; 62( 5): E147-E152.[citado 2025 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53815
Artigo de periodico
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey (2023)
Hoff, Leonardo Santos; Ravichandran, Naveen; Shinjo, Samuel Katsuyuki ; Day, Jessica; Sen, Parikshit; Junior, Jucier Goncalves; Lilleker, James B.; Joshi, Mrudula; Agarwal, Vishwesh; Kardes, Sinan
Fonte: RHEUMATOLOGY INTERNATIONAL. Unidade: FM
Assuntos: COVID-19, INFECÇÕES POR CORONAVIRUS, DOENÇAS AUTOIMUNES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOFF, Leonardo Santos et al. COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey. RHEUMATOLOGY INTERNATIONAL, v. 43, n. 1, p. 47-58, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57854. Acesso em: 03 nov. 2025.
APA
Hoff, L. S., Ravichandran, N., Shinjo, S. K., Day, J., Sen, P., Junior, J. G., et al. (2023). COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey. RHEUMATOLOGY INTERNATIONAL, 43( 1), 47-58. doi:10.1007/s00296-022-05229-7
NLM
Hoff LS, Ravichandran N, Shinjo SK, Day J, Sen P, Junior JG, Lilleker JB, Joshi M, Agarwal V, Kardes S. COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey [Internet]. RHEUMATOLOGY INTERNATIONAL. 2023 ; 43( 1): 47-58.[citado 2025 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57854
Vancouver
Hoff LS, Ravichandran N, Shinjo SK, Day J, Sen P, Junior JG, Lilleker JB, Joshi M, Agarwal V, Kardes S. COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey [Internet]. RHEUMATOLOGY INTERNATIONAL. 2023 ; 43( 1): 47-58.[citado 2025 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57854
Artigo de periodico
High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey (2023)
Grignaschi, Silvia; Kim, Minchul; Zanframundo, Giovanni; Ravichandran, Naveen ; Lilleker, James B. ; Sen, Parikshit ; Joshi, Mrudula; Agarwal, Vishwesh ; Kardes, Sinan ; Day, Jessica ; Shinjo, Samuel Katsuyuki
Fonte: Rheumatology international. Unidade: FM
Assuntos: DOENÇAS AUTOIMUNES, QUESTIONÁRIOS, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GRIGNASCHI, Silvia et al. High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey. Rheumatology international, v. 43, n. 9, p. 1637-1649, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/55990. Acesso em: 03 nov. 2025.
APA
Grignaschi, S., Kim, M., Zanframundo, G., Ravichandran, N., Lilleker, J. B., Sen, P., et al. (2023). High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey. Rheumatology international, 43( 9), 1637-1649. doi:10.1007/s00296-023-05344-z
NLM
Grignaschi S, Kim M, Zanframundo G, Ravichandran N, Lilleker JB, Sen P, Joshi M, Agarwal V, Kardes S, Day J, Shinjo SK. High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey [Internet]. Rheumatology international. 2023 ; 43( 9): 1637-1649.[citado 2025 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55990
Vancouver
Grignaschi S, Kim M, Zanframundo G, Ravichandran N, Lilleker JB, Sen P, Joshi M, Agarwal V, Kardes S, Day J, Shinjo SK. High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey [Internet]. Rheumatology international. 2023 ; 43( 9): 1637-1649.[citado 2025 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55990
Artigo de periodico
Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey (2023)
Yoshida, Akira ; Kim, Minchul; Kuwana, Masataka ; Ravichandran, Naveen ; Makol, Ashima; Sen, Parikshit; Lilleker, James B. ; Agarwal, Vishwesh; Kardes, Sinan; Day, Jessica ; Shinjo, Samuel Katsuyuki
Fonte: Rheumatology. Unidade: FM
Assuntos: APTIDÃO FÍSICA, MANIFESTAÇÕES NEUROMUSCULARES, QUALIDADE DE VIDA, QUESTIONÁRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YOSHIDA, Akira et al. Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey. Rheumatology, v. 62, n. 3, p. 1204-1215, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53805. Acesso em: 03 nov. 2025.
APA
Yoshida, A., Kim, M., Kuwana, M., Ravichandran, N., Makol, A., Sen, P., et al. (2023). Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey. Rheumatology, 62( 3), 1204-1215. doi:10.1093/rheumatology/keac441
NLM
Yoshida A, Kim M, Kuwana M, Ravichandran N, Makol A, Sen P, Lilleker JB, Agarwal V, Kardes S, Day J, Shinjo SK. Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey [Internet]. Rheumatology. 2023 ; 62( 3): 1204-1215.[citado 2025 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53805
Vancouver
Yoshida A, Kim M, Kuwana M, Ravichandran N, Makol A, Sen P, Lilleker JB, Agarwal V, Kardes S, Day J, Shinjo SK. Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey [Internet]. Rheumatology. 2023 ; 62( 3): 1204-1215.[citado 2025 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53805
Artigo de periodico
COVID-19 vaccination in autoimmune disease (COVAD) survey protocol (2022)
Sen, Parikshit; Gupta, Latika; Lilleker, James B; Aggarwal, Vishwesh; Kardes, Sinan; Milchert, Marcin; Gheita, Tamer; Salim, Babur; Velikova, Tsvetelina; Shinjo, Sueli Mieko Oba
Fonte: Rheumatology international. Unidade: FM
Assuntos: COVID-19, PANDEMIAS, DOENÇAS AUTOIMUNES, VACINAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SEN, Parikshit et al. COVID-19 vaccination in autoimmune disease (COVAD) survey protocol. Rheumatology international, v. 42, n. 1, p. 23-29, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00296-021-05046-4. Acesso em: 03 nov. 2025.
APA
Sen, P., Gupta, L., Lilleker, J. B., Aggarwal, V., Kardes, S., Milchert, M., et al. (2022). COVID-19 vaccination in autoimmune disease (COVAD) survey protocol. Rheumatology international, 42( 1), 23-29. doi:10.1007/s00296-021-05046-4
NLM
Sen P, Gupta L, Lilleker JB, Aggarwal V, Kardes S, Milchert M, Gheita T, Salim B, Velikova T, Shinjo SMO. COVID-19 vaccination in autoimmune disease (COVAD) survey protocol [Internet]. Rheumatology international. 2022 ; 42( 1): 23-29.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1007/s00296-021-05046-4
Vancouver
Sen P, Gupta L, Lilleker JB, Aggarwal V, Kardes S, Milchert M, Gheita T, Salim B, Velikova T, Shinjo SMO. COVID-19 vaccination in autoimmune disease (COVAD) survey protocol [Internet]. Rheumatology international. 2022 ; 42( 1): 23-29.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1007/s00296-021-05046-4
Artigo de periodico
COVAD survey 2 long-term outcomes: unmet need and protocol (2022)
Fazal, Zoha Zahid; Sen, Parikshit; Joshi, Mrudula; Ravichandran, Naveen; Lilleker, James B; Agarwal, Vishwesh; Kardes, Sinan; Kim, Minchul; Day, Jessica; Shinjo, Samuel Katsuyuki
Fonte: Rheumatology international. Unidade: FM
Assuntos: DOENÇAS AUTOIMUNES, COVID-19, VACINAÇÃO, PANDEMIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAZAL, Zoha Zahid et al. COVAD survey 2 long-term outcomes: unmet need and protocol. Rheumatology international, v. 42, n. 12, p. 2151-2158, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00296-022-05157-6. Acesso em: 03 nov. 2025.
APA
Fazal, Z. Z., Sen, P., Joshi, M., Ravichandran, N., Lilleker, J. B., Agarwal, V., et al. (2022). COVAD survey 2 long-term outcomes: unmet need and protocol. Rheumatology international, 42( 12), 2151-2158. doi:10.1007/s00296-022-05157-6
NLM
Fazal ZZ, Sen P, Joshi M, Ravichandran N, Lilleker JB, Agarwal V, Kardes S, Kim M, Day J, Shinjo SK. COVAD survey 2 long-term outcomes: unmet need and protocol [Internet]. Rheumatology international. 2022 ; 42( 12): 2151-2158.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1007/s00296-022-05157-6
Vancouver
Fazal ZZ, Sen P, Joshi M, Ravichandran N, Lilleker JB, Agarwal V, Kardes S, Kim M, Day J, Shinjo SK. COVAD survey 2 long-term outcomes: unmet need and protocol [Internet]. Rheumatology international. 2022 ; 42( 12): 2151-2158.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1007/s00296-022-05157-6

Unidades USP

ReP

Filtros

Autores

Assuntos

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos